Cultural Adaptation and Feasibility Evaluation of Metacognitive Training for Patients with Depression in Pakistan: A Randomized Controlled Trial

How to cite

khattak, sundus. 2022. "Cultural Adaptation and Feasibility Evaluation of Metacognitive Training for Patients with Depression in Pakistan: A Randomized Controlled Trial." AEA RCT Registry. AEARCTR-0009520. https://doi.org/10.1257/rct.9520-2.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

sundus khattak*

* Primary investigator

Registry ID
AEARCTR-0009520
DOI
https://doi.org/10.1257/rct.9520-2.0
First registered
Last updated
Status
Completed
Trial dates
2022-06-01 – 2022-12-19
Countries
Pakistan ()
Registry record
http://www.socialscienceregistry.org/trials/9520

Abstract

Depression is the leading cause of disability worldwide. According to the United Nations health agency, it affects more than 300 million people around the world. Previous studies have suggested different psychological interventions to reduce the severity of depression symptoms in developing countries. In Pakistan, there has been a lack of research to address this issue and introduce measures to overcome this gap. This study aimed to develop an intervention to improve the severity of symptoms in individuals with depression in Pakistan. The purpose of this research was to cross-culturally validate the Metacognitive Training for Depression (D-MCT) and evaluate the feasibility and acceptability of delivering D-MCT to individuals within Pakistan. This study was a pre-post design, parallel two arm, double blinded, feasibility, randomized controlled trial. Sixty participants (experimental group, n=30; control group, n=30) were recruited from the departments of psychiatry of a hospitals in Rawalpindi from August to November 2022. Four instruments (Beck Depression Inventory, Metacognitions Questionnire-30, Mental Health Curriculum-Short Form and World Health Organization Quality of Life scale) were used to assess symptom severity, metacognitions, mental health, and quality of life in individuals with depression. A two-way factorial ANOVA was used to examine the efficacy of D-MCT in reducing symptom severity, metacognitions, mental health, and quality of life. The results of this study demonstrated that D-MCT was effective in reducing symptom severity, maladaptive metacognitions in patients with depression as compared to the treatment as usual. On the other hand, the results also revealed that D-MCT was effective in improving quality of life and mental health in patients with depression. This study will help improve depression treatment in Pakistan and create insight in policy makers so they can incorporate this therapy in various hospitals across the country.

Intervention

Metacognitive Training for Depression (D-MCT) is an intervention program given by Lena Jelinek and Steffen Moritz. It is a new treatment approach based on Cognitive-behavior therapy that endorses a metacognitive perspective for the alteration of biases in thought and unhealthy beliefs. D-MCT is easy to administer and highly accepted by the patients (Jelinek et al., 2016). D-MCT is the first standardized treatment approach focused on the metacognitive viewpoint that systematically tackles various depression-related cognitive biases. It focuses on dysfunctional metacognitive coping mechanisms (such as thought suppression and rumination) to address disorder-specific cognitive biases (Hasson-Ohayon & Lysaker, 2021). D-MCT has been translated in more than 10 languages and has been conducting since 2009. Through creative techniques, metacognitive training for depression aims to educate participants about the incorrect thought patterns frequently present in depression. It is a standardize treatment approach, consisting of eight modules in form of power point slides along with homework worksheets.

Experimental design

Study design: Pre and Post Follow-up/Baseline design.

Trial design: A Parallel two-arm, Double-blind, feasibility randomized controlled trial.

Design details

Randomization method
Randomization is done in-office by a random number generator.
Randomization unit
individual
Clusters
data will be collected from a single hospital.
Observations
60 individuals diagnosed with depression.
Arms
60 participants will be divided into 2 groups/arms (1:1 allocation in each arm): Intervention group/arm= 30 participants Compensatory/control group/arm= 30 participants
Primary outcomes
Severity of depression was evaluated through Beck Depression Inventory (BDI).
Secondary outcomes
Quality of life:WHO Quality of Life scale (WHOQOL-BREF) Positive mental health: Positive Mental Health Scale(PMH) Metacognitions:Metacognitions Questionnaire 30 (MCQ-30)

Cited by

No citation data available for this registration yet.

Keywords